Koers TetraLogic Pharmaceuticals Corporation Other OTC
Aandelen
TLOG
US88165U1097
Biotechnologie & Medisch Onderzoek
Omzet 2014 | - | Omzet 2015 | - | Marktkapitalisatie | 42,07 mln. 39,21 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -36 mln. -33,55 mln. | Nettowinst (verlies) 2015 | -49 mln. -45,67 mln. | EV/omzet 2014 | - |
Nettoliquiditeiten 2014 | 22,32 mln. 20,8 mln. | Nettoschuld 2015 | 7,92 mln. 7,39 mln. | EV/omzet 2015 | - |
K/w-verhouding 2014 |
-2,96
x | K/w-verhouding 2015 |
-0,82
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
President | - | - | |
Treasurer | 66 | 01-02-14 | |
Dick L. Sherman
SEC | Corporate Secretary | 76 | 01-11-12 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,70% | 121 mld. | |
+19,65% | 113 mld. | |
+17,47% | 26,02 mld. | |
-25,33% | 19,39 mld. | |
-19,51% | 15,91 mld. | |
-19,10% | 15,09 mld. | |
-46,87% | 15,06 mld. | |
+63,63% | 14,93 mld. | |
+5,71% | 13,85 mld. |